Status:
NOT_YET_RECRUITING
Fiberoptic Evaluation of i-Gel and Air-Q sp3G Supraglottic Airway Devices in Pediatric Patients
Lead Sponsor:
Ankara City Hospital Bilkent
Conditions:
Laryngeal Mask Airways
Fiberoptic Bronchoscopy (FOB)
Eligibility:
All Genders
1-8 years
Brief Summary
This single-center, prospective, randomized controlled study aims to compare the placement accuracy of iGel and Air-Q sp3G supraglottic airway (SGA) devices in pediatric patients aged 1-8 years underg...
Detailed Description
This single-center, prospective, randomized controlled trial will be conducted in pediatric patients aged 1-8 years undergoing elective pediatric or urological surgery under general anesthesia. Partic...
Eligibility Criteria
Inclusion
- Age 1-8 years
- ASA I-III
- Elective pediatric or urological surgery under general anesthesia with SGA use
- Informed consent obtained from parents/guardians
Exclusion
- Parental refusal or inability to consent
- ASA \> III
- Recent or current upper respiratory tract infection
- History of difficult airway
- Increased aspiration risk
- Urgent/emergency surgery or non-fasted patients
- Known allergy or contraindication to anesthetic agents
- Severe asthma (attack within last 6 months)
- Structural airway anomalies
- Gastrointestinal pathology affecting stomach emptying
- Previous stomach surgery
Key Trial Info
Start Date :
August 22 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 20 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT07141498
Start Date
August 22 2025
End Date
January 20 2026
Last Update
August 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Bilkent City Hospital, Department Of Anesthesiology and Reanimation
Ankara, Turkey (Türkiye)